00:53:37 EDT Tue 09 Jun 2026
Enter Symbol
or Name
USA
CA



Q:XRTX - XORTX THERAPEUTICS INC - https://www.xortx.com/
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
XRTX - Q0.11.96·10.002.32.18-0.02-0.918.6356352.175  2.29  2.107.05  1.72519:14:00May 1915 min RT 2¢

Recent Trades - Last 10 of 635
Time ETExPriceChangeVolume
19:14:00Q2.1814-0.02861
16:52:37Q2.230.0250
16:45:19Q2.1807-0.029350
16:10:04Q2.18-0.031
16:04:02Q2.18-0.031
16:00:00Q2.18-0.036
16:00:00Q2.18-0.034
16:00:00Q2.18-0.033
16:00:00Q2.18-0.031
16:00:00Q2.18-0.035

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-05-19 07:00U:XRTXNews ReleaseXORTX Announces Closing of US$5 Million Public Offering
2026-05-18 11:21U:XRTXNews ReleaseE.F. Hutton & Co. Serves as Exclusive Placement Agent on XORTX Therapeutics Inc. $5 Million Public Offering
2026-05-14 07:00U:XRTXNews ReleaseXORTX Announces US$5 Million Public Offering
2026-04-21 07:00U:XRTXNews ReleaseXORTX Meets Nasdaq Continued Listing Requirements
2026-04-13 17:00U:XRTXNews ReleaseXORTX Announces Closing of Acquisition of Vectus Kidney Anti-fibrotic Asset
2026-04-01 13:00U:XRTXNews ReleaseXORTX Confirms Effective Date of Share Consolidation
2026-03-26 18:00U:XRTXNews ReleaseXORTX Announces Results of Annual and Special Meeting of Shareholders
2026-03-26 16:33U:XRTXNews ReleaseXORTX Announces Change of Effective Date of Share Consolidation
2026-03-25 18:15U:XRTXNews ReleaseXORTX Announces Share Consolidation
2026-03-24 17:00U:XRTXNews ReleaseXORTX Reports that Shareholders Approved the Share Consolidation at the Annual General Meeting
2026-03-18 07:00U:XRTXNews ReleaseXORTX Announces Substitute Director Nominees for its Upcoming Annual and Special Meeting of Shareholders
2026-03-13 07:00U:XRTXNews ReleaseXORTX Reports that Independent Proxy Advisory Firms Recommend XORTX Shareholders Vote "For" the Share Consolidation
2026-03-05 07:00U:XRTXNews ReleaseXORTX Announces Filing and Mailing of the Meeting Documents in Connection with the Annual and Special Meeting of Shareholders
2026-02-04 18:00U:XRTXNews ReleaseXORTX Provides Update on Acquisition of Renal Anti-Fibrotic Therapeutic Program from Vectus Biosystems
2025-12-31 18:15U:XRTXNews ReleaseXORTX Announces Pioneering Research on Genome-Wide Pathogenic Pathways in Gout and Provides a Corporate Update
2025-10-29 07:00U:XRTXNews ReleaseXORTX Announces Closing of US$1.1 Million Registered Direct Offering
2025-10-21 08:00U:XRTXNews ReleaseXORTX Announces Pricing of US$1.1 Million Registered Direct Offering
2025-10-20 20:35U:XRTXNews ReleaseXORTX Issues Correction Notice and XORTX Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Deficiency
2025-10-20 18:45U:XRTXNews ReleaseXORTX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
2025-10-17 07:00U:XRTXNews ReleaseXORTX Announces Acquisition of Renal Anti-Fibrotic Therapeutic Program from Vectus Biosystems